Search results
1 hour ago · Eli Lilly & Co., a global leader in pharmaceuticals, has announced the acquisition of Morphic Holding Inc., a US-based biotech company specializing in treatments for gut diseases. This $3.2 billion deal marks a strategic investment for Lilly, aiming to strengthen its experimental pipeline and expand its presence in immunology.
1 day ago · Acquisition to expand Lilly's immunology pipeline with oral integrin therapies . INDIANAPOLIS and WALTHAM, Mass., July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.
1 day ago · Lilly reported revenues of $8.77 billion in the last reported quarter, representing a year-over-year change of +26%. EPS of $2.58 for the same period compares with $1.62 a year ago. Compared to ...
3 days ago · Latest Eli Lilly and Co (LLY:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
People also ask
Where is Eli Lilly headquartered?
When was Eli Lilly founded?
What is Eli Lilly & Co?
How many employees does Eli Lilly & Company have?
4 days ago · Get a real-time Eli Lilly and Company (LLY) stock price quote with breaking news, financials, statistics, charts and more.
8 hours ago · Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes ...
5 days ago · Company profile for Eli Lilly and Company (LLY) with a description, list of executives, contact details and other key facts.